Area of research
Hematology · Oncology
Research interest
Research interests include Medicine, Internal medicine, Cancer, Coronavirus disease 2019 (COVID-19), Pneumonia, and Ruxolitinib.
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 <sup>+</sup> Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
Improving Diagnosis of Pulmonary Mucormycosis
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome